Acurx Pharmaceuticals (ACXP) Institutional Ownership → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free ACXP Stock Alerts $2.25 +0.09 (+4.17%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Acurx Pharmaceuticals (NASDAQ:ACXP)CurrentInstitutional OwnershipPercentage11.53%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$1.13MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.02M Get ACXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Acurx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACXP Institutional Buying and Selling by Quarter Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Acurx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/23/2024 Prospect Financial Services LLC272,850$668K0.6%+6.9%1.732% 4/5/2024 NBC Securities Inc.14,000$34K0.0%N/A0.089% 2/20/2024 Prospect Financial Services LLC255,150$977K1.0%N/A1.853% 2/1/2024 Sigma Planning Corp10,000$38K0.0%N/A0.073% 11/15/2023 Armistice Capital LLC500,000$750K0.0%-57.7%3.843% 8/14/2023One68 Global Capital LLC13,044$35K0.2%N/A0.101% 11/14/2022 Armistice Capital LLC1,066,000$3.20M0.1%N/A9.224% 8/12/2022 Semmax Financial Advisors Inc.5,879$28K0.0%+365.5%0.057% 8/1/2022 Castle Wealth Management LLC13,000$49K0.0%N/A0.127% 1/10/2022 Patriot Financial Group Insurance Agency LLC7,000$30K0.0%+75.0%0.069% 11/15/2021 Tocqueville Asset Management L.P.19,100$98K0.0%+91.0%0.189% 11/9/2021 BlackRock Inc.6,515$33K0.0%N/A0.064% 8/16/2021 Tocqueville Asset Management L.P.10,000$64K0.0%N/A0.105% (Data available from 1/1/2016 forward) ACXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACXP shares? During the previous two years, the following institutional investors and hedge funds held shares of Acurx Pharmaceuticals shares: Armistice Capital LLC ($750K), Prospect Financial Services LLC ($668K), Castle Wealth Management LLC ($49K), Sigma Planning Corp ($38K), One68 Global Capital LLC ($35K), and NBC Securities Inc. ($34K), and Semmax Financial Advisors Inc. ($28K).Learn more on ACXP's institutional investors. What percentage of Acurx Pharmaceuticals stock is owned by institutional investors? 11.53% of Acurx Pharmaceuticals stock is owned by institutional investors. Learn more on ACXP's institutional investor holdings. Which institutional investors have been buying Acurx Pharmaceuticals stock? The following institutional investors have purchased Acurx Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($1.07M), Prospect Financial Services LLC ($272.85K), NBC Securities Inc. ($14K), One68 Global Capital LLC ($13.04K), Castle Wealth Management LLC ($13K), Sigma Planning Corp ($10K), and Semmax Financial Advisors Inc. ($4.62K). How much institutional buying is happening at Acurx Pharmaceuticals? Institutional investors have bought a total of 1,393,510 shares in the last 24 months. This purchase volume represents approximately $4.39M in transactions. Which Acurx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Acurx Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($682K). How much institutional selling is happening at Acurx Pharmaceuticals? Institutional investors have sold a total of 682,000 shares in the last 24 months. This volume of shares sold represents approximately $1.02M in transactions. Related Companies: NRx Pharmaceuticals Major Shareholders BriaCell Therapeutics Major Shareholders Fortress Biotech Major Shareholders Aprea Therapeutics Major Shareholders Spruce Biosciences Major Shareholders Apollomics Major Shareholders Daré Bioscience Major Shareholders ImmunoPrecise Antibodies Major Shareholders Viracta Therapeutics Major Shareholders Theratechnologies Major Shareholders This page (NASDAQ:ACXP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.